[
    [
        {
            "time": "",
            "original_text": "医药生物行业专题研究：从壁垒出发寻找医美领域的确定性机遇",
            "features": {
                "keywords": [
                    "医药生物",
                    "专题研究",
                    "壁垒",
                    "医美",
                    "确定性",
                    "机遇"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物",
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药生物行业专题研究：从壁垒出发寻找医美领域的确定性机遇",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "华熙生物(688363)：收入业绩增速提升 品牌元年值得期待",
            "features": {
                "keywords": [
                    "华熙生物",
                    "688363",
                    "收入",
                    "业绩",
                    "增速",
                    "品牌",
                    "元年",
                    "期待"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华熙生物(688363)：收入业绩增速提升 品牌元年值得期待",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]